Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study, Rheumatology International, March 2017, Springer Science + Business Media,
DOI: 10.1007/s00296-017-3682-9.
You can read the full text:

Read

Contributors

The following have contributed to this page